Jane Street Group, LLC Forte Biosciences, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.65 - $1.04 $6,995 - $11,193
10,763 New
10,763 $7,000
Q3 2021

Nov 16, 2021
BUY
$2.96 - $36.67 $343,558 - $4.26 Million
116,067 New
116,067 $344,000
Q4 2020

Feb 17, 2021
SELL
$28.66 - $46.79 $377,423 - $616,177
-13,169 Closed
0 $0
Q3 2020

Nov 17, 2020
BUY
$14.71 - $50.69 $43,821 - $151,005
2,979 Added 29.23%
13,169 $639,000
Q2 2020

Aug 17, 2020
BUY
$13.9 - $24.6 $141,641 - $250,674
10,190 New
10,190 $149,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $114M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email